Evidence map›Paper›PMID 25352949›Full record

ArticleGenes & cancer2014

TGF-β induced TMEPAI/PMEPA1 inhibits canonical Smad signaling through R-Smad sequestration and promotes non-canonical PI3K/Akt signaling by reducing PTEN in triple negative breast cancer.

Prajjal K Singha, Srilakshmi Pandeswara, Hui Geng, Rongpei Lan, Manjeri A Venkatachalam, Pothana Saikumar

Open access · diamondAbstract read
In one paragraph

Article in Genes & cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Comprehensive Analysis of the Expression of TGF-Computational and mathematical methods in medicine · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Biomolecules · 2020
    Review
  20. The TGF-b/SOX4 axis and ROS-driven autophagy co-mediate CD39 expression in regulatory T-cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Prajjal K SinghaFrom the Department of Pathology, UT Health Science Center at San Antonio, TX.
Srilakshmi PandeswaraDepartment of Med/Hematology & Med Oncology, UT Health Science Center at San Antonio, TX.
Hui GengFrom the Department of Pathology, UT Health Science Center at San Antonio, TX.
Rongpei LanFrom the Department of Pathology, UT Health Science Center at San Antonio, TX.
Manjeri A VenkatachalamFrom the Department of Pathology, UT Health Science Center at San Antonio, TX.
Pothana SaikumarFrom the Department of Pathology, UT Health Science Center at San Antonio, TX.
The University of Texas Health Science Center at Houston · USThe University of Texas Health Science Center at San Antonio · US

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Lei Zheng · 1991 to 2026
$59.1M
PTEN REGULATION DURING ISCHEMIC ACUTE RENAL FAILURER01DK037139 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI VENKATACHALAM, MANJERI A · 1987 to 2008
$2.3M
MEMBRANE PATHOLOGY IN RENAL CELL INJURYR37DK037139 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI VENKATACHALAM, MANJERI A · 1996 to 2003
$1.8M
NCI NIH HHS P30 CA054174NIDDK NIH HHS R01 DK037139NIDDK NIH HHS R37 DK037139
6 · The paper itself

Abstract

TMEPAI (transmembrane prostate androgen-induced) is amplified at genomic, transcript and protein levels in triple-negative breast cancers and promotes TGF-β dependent growth, motility and invasion. Tumor promotion by TMEPAI depends on two different but related actions on TGF-β signaling. Firstly, TMEPAI binds and sequesters regulatory Smads2/3 and thereby decreases growth suppressive signaling by TGF-β. Secondly, increased expression of TMEPAI decreases PTEN (phosphatase and tensin homolog) abundance, and thereby increases TGF-β dependent tumor promotive PI3K/Akt signaling. These actions of TMEPAI give rise to increased cell proliferation and motility. Moreover, signaling alterations produced by high TMEPAI were associated with oncogenic Snail expression and lung metastases. Finally, an inverse correlation between TMEPAI and PTEN levels was confirmed in triple negative breast cancer tumor samples. Together, our findings suggest that TMEPAI has dually critical roles to promote TGF-β dependent cancer cell growth and metastasis. Thus, redirected TGF-β signaling through TMEPAI may play a pivotal role in TGF-β mediated tumor promotion.

Indexed as

PMEPA1PTENSmadTGF-βTMEPAITriple Negative Breast Cancer (TNBC)

Identifiers

PMID25352949
PMCPMC4209604
OpenAlexW152275866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.